Cowen and Company’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Cowen and Company’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-679,393	Closed	-$7.36M	–	795
2023 Q3	$7.36M	Buy	+679,393	New	+$7.29M	0.52%	44

Cowen and Company's BIOS Position: Q4 2023 in Review

Cowen and Company sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 679,393 shares — an estimated $7.36M sold.

Cowen and Company first reported a position in BIOS in Q3 2023 and held it in 1 quarter. The position peaked at $7.36M in Q3 2023. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

Cowen and Company reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Cowen and Company sold 679,393 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $7.36M.
Cowen and Company first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q3 2023 and held it in 1 quarter.
Cowen and Company's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $7.36M in Q3 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.